ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
57 hedge funds and large institutions have $21.3M invested in Zynerba Pharmaceuticals, Inc in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Holders
57
Holding in Top 10
–
Calls
$1.63M
Puts
$1.29M
Top Buyers
| 1 | +$3.05M | |
| 2 | +$849K | |
| 3 | +$801K | |
| 4 |
Renaissance Technologies
New York
|
+$414K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$392K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$326K | |
| 3 | -$171K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$162K |
| 5 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
-$123K |